Document Detail

Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia.
MedLine Citation:
PMID:  20001969     Owner:  NLM     Status:  MEDLINE    
Despite the evidence in experimental animal models that insulin, or GIK (glucose-insulin-potassium), improves left ventricular function and perfusion during both acute and chronic ischaemia, clinical studies have generated conflicting results. We tested the hypothesis that pretreatment with GIK attenuates the vascular and functional effects of stress-induced myocardial ischaemia in humans. Twenty-two patients with evidence of inducible myocardial ischaemia were enrolled; 11 patients with normal ventricular function underwent two dipyridamole echocardiography tests, and 11 with regional contractility defects from previous myocardial infarction were submitted to two ECG exercise tests combined with 201Tl myocardial perfusion scintigraphy; the tests were preceded by 60 min of either normal saline or an isoglycaemic GIK infusion. On a stress echocardiogram, a 30% reduction in the severity of ischaemia was observed. On ECG ergometry, GIK infusion slightly increased the time to ischaemia (+0.6 min, P=0.07); however, the higher workload (+8%, P=0.07) was achieved at a similar rate-pressure plateau. On scintigraphy, an increase in ischaemic segments (+48%, P<0.001) was imaged mainly at the expense of viable (but non-ischaemic) and non-viable segments, which were reduced by 60%. GIK affected stress-induced left ventricular underperfusion only marginally (GIK: 39.7+/-2.5 compared with saline: 35.4+/-2.2 units, P<0.05), but significantly improved its acute reversibility (-42+/-4 compared with -25+/-4%, P<0.001). We conclude that GIK pretreatment attenuates the effect of ischaemia on myocardial contractility, slightly improves exercise tolerance and causes a more rapid and diffuse recovery of post-ischaemic reperfusion.
Stefano Di Marco; Beatrice Boldrini; Umberto Conti; Gabriella Marcucci; Cecilia Morgantini; Ele Ferrannini; Andrea Natali
Related Documents :
10147729 - Echocardiography in coronary artery disease.
679229 - Comparative haemodynamic and metabolic effects of vasodilator and inotropic agents in e...
7915979 - Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced car...
7922829 - Awareness and control of the cardiovascular response to stress among men with and witho...
25494279 - Prehospital ticagrelor in st-segment elevation myocardial infarction.
8680139 - Adenosine triphosphate stress echocardiography in the detection of myocardial ischemia.
3168199 - Autonomic mechanisms and sudden death. new insights from analysis of baroreceptor refle...
1554539 - Clinical and angiographic prediction of cardiac death after coronary artery bypass graf...
16339839 - The ppar-alpha activator fenofibrate fails to provide myocardial protection in ischemia...
Publication Detail:
Type:  Controlled Clinical Trial; Journal Article     Date:  2010-04-07
Journal Detail:
Title:  Clinical science (London, England : 1979)     Volume:  119     ISSN:  1470-8736     ISO Abbreviation:  Clin. Sci.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-04-07     Completed Date:  2010-07-29     Revised Date:  2010-09-23    
Medline Journal Info:
Nlm Unique ID:  7905731     Medline TA:  Clin Sci (Lond)     Country:  England    
Other Details:
Languages:  eng     Pagination:  37-44     Citation Subset:  IM    
Division of Cardiology, Pescia General Hospital, Pescia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose / metabolism
Cardioplegic Solutions / therapeutic use*
Echocardiography, Stress / methods
Exercise Test / methods
Exercise Tolerance / physiology
Glucose / therapeutic use
Insulin / blood,  therapeutic use
Middle Aged
Myocardial Contraction / physiology
Myocardial Ischemia / prevention & control*,  radionuclide imaging,  ultrasonography
Potassium / blood,  therapeutic use
Stress, Physiological / physiology
Reg. No./Substance:
0/Blood Glucose; 0/Cardioplegic Solutions; 0/glucose-insulin-potassium cardioplegic solution; 11061-68-0/Insulin; 50-99-7/Glucose; 7440-09-7/Potassium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Amyloid ?-peptide directly induces spontaneous calcium transients, delayed intercellular calcium wav...
Next Document:  Thr-435 phosphorylation regulates RelA (p65) NF-kappaB subunit transactivation.